Scott Schoenhaus
Stock Analyst at KeyBanc
(0.10)
# 4,338
Out of 4,408 analysts
198
Total ratings
33.1%
Success rate
-11.8%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Rated: Buy | $55 → $90 | $65.34 | +37.74% | 4 | Jun 12, 2026 | |
| ODD Oddity Tech | Downgraded: Hold | n/a | $11.72 | - | 10 | Jun 2, 2026 | |
| HQY HealthEquity | Maintained: Buy | $125 | $88.34 | +41.50% | 16 | May 26, 2026 | |
| DOCS Doximity | Maintained: Hold | n/a | $20.04 | - | 12 | May 14, 2026 | |
| ZTS Zoetis | Maintained: Hold | n/a | $79.57 | - | 1 | May 8, 2026 | |
| OMCL Omnicell | Rated: Buy | $60 → $70 | $37.83 | +85.04% | 15 | Apr 29, 2026 | |
| PHR Phreesia | Rated: Buy | $32 → $12 | $9.06 | +32.45% | 14 | Apr 13, 2026 | |
| SDGR Schrödinger | Rated: Buy | $25 → $20 | $14.45 | +38.41% | 11 | Apr 13, 2026 | |
| CERT Certara | Rated: Buy | $10 → $8 | $5.20 | +53.85% | 9 | Apr 13, 2026 | |
| LFMD LifeMD | Maintained: Buy | n/a | $4.70 | - | 8 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.21 | - | 1 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $28 | $26.63 | +5.14% | 13 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.34 | - | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $29 | $24.17 | +19.98% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7639 | - | 11 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.85 | - | 7 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.65 | - | 10 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $159.54 | - | 17 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.32 | - | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $5 | $5.24 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $9 | $6.80 | n/a | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $8.50 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $3.15 | n/a | 7 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.80 | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $175 → $250 | $181.46 | n/a | 3 | Apr 16, 2021 |
Hinge Health
Jun 12, 2026
Rated: Buy
Price Target: $55 → $90
Current: $65.34
Upside: +37.74%
Oddity Tech
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $11.72
Upside: -
HealthEquity
May 26, 2026
Maintained: Buy
Price Target: $125
Current: $88.34
Upside: +41.50%
Doximity
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $20.04
Upside: -
Zoetis
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $79.57
Upside: -
Omnicell
Apr 29, 2026
Rated: Buy
Price Target: $60 → $70
Current: $37.83
Upside: +85.04%
Phreesia
Apr 13, 2026
Rated: Buy
Price Target: $32 → $12
Current: $9.06
Upside: +32.45%
Schrödinger
Apr 13, 2026
Rated: Buy
Price Target: $25 → $20
Current: $14.45
Upside: +38.41%
Certara
Apr 13, 2026
Rated: Buy
Price Target: $10 → $8
Current: $5.20
Upside: +53.85%
LifeMD
Mar 11, 2026
Maintained: Buy
Price Target: n/a
Current: $4.70
Upside: -
Mar 10, 2026
Maintained: Hold
Price Target: n/a
Current: $5.21
Upside: -
Mar 2, 2026
Reiterated: Buy
Price Target: $32 → $28
Current: $26.63
Upside: +5.14%
Feb 27, 2026
Maintained: Hold
Price Target: n/a
Current: $7.34
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: $27 → $29
Current: $24.17
Upside: +19.98%
Feb 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.7639
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $1.85
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $2.65
Upside: -
Dec 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $159.54
Upside: -
Oct 29, 2025
Maintained: Hold
Price Target: n/a
Current: $16.32
Upside: -
Apr 16, 2025
Maintained: Buy
Price Target: $4 → $5
Current: $5.24
Upside: n/a
Apr 16, 2025
Maintained: Buy
Price Target: $5 → $9
Current: $6.80
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $8.50
Upside: n/a
Jan 8, 2025
Maintained: Buy
Price Target: $12 → $10
Current: $3.15
Upside: n/a
Sep 15, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $4.80
Upside: n/a
Apr 16, 2021
Upgraded: Buy
Price Target: $175 → $250
Current: $181.46
Upside: n/a